ENERGIZE THE FIGHT.

accelerators logo

GIVE THE GIFT OF ENERGY

See how you can help families
like Patrick’s this holiday season

Image

BREAKING NEWS: FDA APPROVES TK2D THERAPY

The U.S. Food and Drug Administration (FDA) has approved UCB’s Kygevvi (doxecitine and doxribtimine) to treat the mitochondrial disease TK2d.  “It’s hard to put into words what today’s decision means for patients living with TK2d,” said UMDF President and CEO Kristen Clifford. READ MORE >>

Need to Connect with Us?

Call the Support Line: (888) 900-6486

Find a Doctor

FIND A MITO DOC 

UMDF maintains a list of 200+ doctors treating and researching mitochondrial disease.

Ways to Give

WE CAN’T DO IT ALONE  

Your involvement is critical to find a cure for mitochondrial disease.

Find an Event

VIEW UMDF EVENTS 

Find a virtual support meeting or UMDF fundraiser in your hometown.

Take Action

BE AN ADVOCATE  

Use your voice to impact legislation affecting the mitochondrial community at the federal and state level.

Find Support

UMDF IS HERE TO HELP 

Get helpful resources, educational info and caring support.

Our Impact

READ IMPACT REPORT 

The work done through UMDF is making a global impact.

UMDF Connect

Ask the Mito Doc – December 2025

Ask the Mito Doc - December 2025: Wrapping Up 2025 with Our Mito Docs    All answers today are based on personal experience of the participants. As always, please consult your personal physician prior to taking any action.Bnech to Bedside - Special Edition: Clinical...

read more